Marco Giorgio Baroni

Author

Also Known As

Antonio Balsamo, BARONI, Marco Giorgio, Baroni, Marco, Francesco Andreozzi, M Baroni, M G Baroni, M. BARONI, M. Baroni, M. G. BARONI, M. G. Baroni

256

Publications

6.7K

Citations

H-Index

145

Concepts

All Affiliations

Sapienza University of Rome University of Cagliari Policlinico Umberto I Istituto Neurologico Mediterraneo University of L'Aquila

About

Marco Giorgio Baroni is an author at Sapienza University of Rome specializing in medicine, metabolic syndrome, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	28	56	2.6K
2	Health Sciences	18	24	1.1K
3	Public Health	14	17	748
4	Engineering	1	1	272
5	Social Sciences	1	1	51

Marco Giorgio Baroni

118

Publications

5.4K

Citations

H-Index

Page 1

	Year	Citations
Strong association between non alcoholic fatty liver disease (NAFLD) and low 25(OH) vitamin D levels in an adult population with normal serum liver enzymes Ilaria Barchetta, Francesco Angelico, Maria Del Ben, BMC Medicine	2011	327
Highly Efficient Palladium-Catalyzed Boronic Acid Coupling Reactions in Water: Scope and Limitations Domenico Badone, Marco Giorgio Baroni, Rosanna Cardamone, The Journal of Organic Chemistry Chemical EngineeringCross-coupling ReactionEngineeringVinylboronic AcidsAryl Iodides	1997	272
Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent Stefano Romeo, Federica Sentinelli, Satya Dash, International Journal of Obesity ObesityMetabolic SyndromeHepatologyLiver PhysiologyGenetic Epidemiology	2009	205
Aminotransferase activity in morbid and uncomplicated obesity: Predictive role of fasting insulin Gianluca Iacobellis, Antonio Moschetta, Raffaella Buzzetti, Nutrition Metabolism and Cardiovascular Diseases ObesityMetabolic SyndromeMetabolic DisorderInsulin ManagementDiabetes	2006	194
No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial Ilaria Barchetta, Maria Del Ben, Francesco Angelico, BMC Medicine	2016	182
The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life Stefano Romeo, Federica Sentinelli, Valentina M. Cambuli, Journal of Hepatology Liver DamageAllelic VariantHepatologyPnpla3 GeneLiver Physiology	2010	159
Association of the human adiponectin gene and insulin resistance Emanuela Filippi, Federica Sentinelli, Vincenzo Trischitta, European Journal of Human Genetics Insulin ResistanceMetabolic SyndromeObesityMetabolic DisorderPhysiology	2003	142
Assessment of Adiponectin and Leptin as Biomarkers of Positive Metabolic Outcomes after Lifestyle Intervention in Overweight and Obese Children Valentina M. Cambuli, M. Cristina Musiu, Michela Incani, The Journal of Clinical Endocrinology & Metabolism	2008	135
Functional identification of rat atypical β‐adrenoceptors by the first β<sub>3</sub>‐selective antagonists, aryloxypropanolaminotetralins L. Manara, Domenico Badone, Marco Giorgio Baroni, British Journal of Pharmacology	1996	124
The adiponectin gene SNP+276G>T associates with early-onset coronary artery disease and with lower levels of adiponectin in younger coronary artery disease patients (age ≤50 years) Emanuela Filippi, Federica Sentinelli, Stefano Romeo, Journal of Molecular Medicine Cardiovascular EpidemiologyCardiovascular DiseaseAge ≤50PhysiologyGenetic Epidemiology	2005	124

Page 1